This resource is part of our Treatment Navigator, a comprehensive guide to common behavioral/mental health diagnoses and the evidence based practices (EBPs) that help these conditions.
Overview
Major Depressive Disorder (MDD) is characterized by persistent low mood, loss of interest or pleasure, and accompanying cognitive, emotional, and physical symptoms that cause significant distress or impairment. Common features include changes in sleep or appetite, fatigue, feelings of worthlessness or guilt, difficulty concentrating, and recurrent thoughts of death or suicide. Episodes last at least two weeks and may range from mild to severe. Treatment focuses on reducing symptom severity, improving functioning, and preventing relapse through structured, evidence-based interventions.
Indicated Evidence-Based Practices (EBPs)
- Cognitive Behavioral Therapy (CBT) – targets negative thinking patterns and behavioral avoidance
- Behavioral Activation (BA) – increases engagement in reinforcing and value-based activities
- Interpersonal Psychotherapy (IPT) – focuses on role transitions, disputes, grief, and interpersonal deficits
- Problem-Solving Therapy (PST) – builds practical coping and decision-making skills
- Acceptance and Commitment Therapy (ACT) – promotes psychological flexibility and values-guided behavior
- Mindfulness-Based Cognitive Therapy (MBCT) – reduces relapse risk in recurrent depression
- Collaborative Care (integrated behavioral health model) – combines therapy, pharmacotherapy, and case management
When to Choose What
CBT and BA have the strongest evidence for acute symptom reduction across mild to moderate depression.
IPT is indicated when interpersonal loss, role change, or conflict is a primary stressor.
PST is well-suited for clients with comorbid medical conditions or chronic stressors.
MBCT is particularly effective for preventing relapse after recovery from multiple depressive episodes.
ACT can help clients who experience self-criticism, experiential avoidance, or difficulty aligning behavior with values.
For moderate to severe depression, combination treatment (psychotherapy plus pharmacotherapy) is recommended per APA and NICE guidelines.
Core Components of Treatment
- Psychoeducation on depression, treatment options, and recovery expectations
- Identification of maintaining factors such as avoidance, rumination, or negative thinking
- Activity scheduling and graded engagement in rewarding or meaningful behavior (Behavioral Activation)
- Cognitive restructuring to challenge distorted thoughts and beliefs (CBT)
- Interpersonal analysis to address conflict, grief, or isolation (IPT)
- Development of problem-solving and coping strategies (PST)
- Mindfulness and acceptance practices to reduce reactivity and rumination (MBCT, ACT)
- Relapse prevention planning and monitoring for early warning signs
Measures and Monitoring
Screening and diagnostic tools
- PHQ-9 (Patient Health Questionnaire-9): measures symptom severity; sensitive to change over time
- HAM-D (Hamilton Rating Scale for Depression): clinician-rated; widely used in research and clinical trials
- BDI-II (Beck Depression Inventory-II): self-report measure of depressive symptom patterns
- QIDS-SR (Quick Inventory of Depressive Symptomatology – Self-Report): efficient symptom monitoring tool
- SCID-5 or MINI (structured interviews) for diagnostic confirmation if needed
Monitoring and outcome tools
- PHQ-9 administered every 2–4 sessions to track treatment response (≥5-point change = clinically meaningful improvement)
- GAD-7 or DASS-21 when anxiety symptoms co-occur
- WHODAS 2.0 or Sheehan Disability Scale for functional outcomes
- Session Rating Scale (SRS) to assess therapeutic alliance
- Ongoing suicide risk assessment (e.g., Columbia Suicide Severity Rating Scale)
Adaptations and Special Considerations
Age and development: Adjust pace and homework for cognitive capacity and energy levels. For older adults, incorporate life review, social engagement, and adaptation for health concerns.
Culture and identity: Explore culturally relevant expressions of depression (e.g., somatic vs. affective focus) and address stigma about help-seeking or emotion expression.
Comorbidity: When anxiety, trauma, or substance use disorders are present, integrate exposure, grounding, or relapse prevention strategies in sequence.
Telehealth: Encourage use of digital mood-tracking tools and secure messaging for between-session check-ins.
Group format: CBT, BA, and IPT have well-validated group protocols that can be cost-effective and normalize depressive experiences.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).
Cuijpers, P., et al. (2021). The effects of psychotherapies for adult depression: A systematic review and meta-analysis. World Psychiatry, 20(2), 294–309.
Dimidjian, S., & Martell, C. R. (2011). Behavioral Activation for Depression: A Clinician’s Guide. Guilford Press.
Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001). Behavioral activation treatment for depression: Returning to contextual roots. Clinical Psychology: Science and Practice, 8(3), 255–270.
Markowitz, J. C., & Weissman, M. M. (2012). Interpersonal Psychotherapy: Principles and Applications. World Psychiatry, 11(1), 19–24.
Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2018). Mindfulness-Based Cognitive Therapy for Depression (2nd ed.). Guilford Press.
Would you like the next diagnosis to be Posttraumatic Stress Disorder (PTSD – adult) or another from your priority list?